Ultragenyx Reports Preliminary 2019 Revenue and Provides 2020 Crysvita Revenue Guidance January 13, 2020
Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications January 13, 2020
Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma January 13, 2020
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership January 13, 2020
Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada January 13, 2020
Tyvyt (Sintilimab Injection) Combined with ALIMTA (Pemetrexed) and Platinum Met Predefined Primary Endpoint in Phase 3 ORIENT-11 Study as First-Line Therapy in Nonsquamous NSCLC January 12, 2020